ClearPoint Neuro Inc. (CLPT)
NASDAQ: CLPT
· Real-Time Price · USD
12.31
-0.12 (-0.97%)
At close: May 15, 2025, 11:50 AM
ClearPoint Neuro Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Biologics and Drug Delivery - Disposable Products Revenue | 5.61M | 2.15M | 3.69M | 3.35M | 5.04M |
| Biologics and Drug Delivery - Disposable Products Revenue Growth | +160.26% | -41.63% | +10.05% | -33.51% | n/a |
| Biologics and Drug Delivery Revenue Revenue | 17.31M | 13.6M | 9.12M | 6.79M | 1.49M |
| Biologics and Drug Delivery Revenue Revenue Growth | +27.26% | +49.14% | +34.22% | +356.04% | n/a |
| Capital Equipment and Software - Services Revenue | 1.06M | 973K | 795K | 569K | n/a |
| Capital Equipment and Software - Services Revenue Growth | +8.94% | +22.39% | +39.72% | n/a | n/a |
| Capital Equipment and Software - Systems and Software Products Revenue | 2.73M | 860K | 1.51M | 864K | n/a |
| Capital Equipment and Software - Systems and Software Products Revenue Growth | +218.02% | -43.12% | +75.00% | n/a | n/a |
| Capital Equipment and Software Revenue Revenue | 3.79M | 1.83M | 2.31M | 1.43M | n/a |
| Capital Equipment and Software Revenue Revenue Growth | +107.04% | -20.55% | +60.99% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.03M | 6.7M | 6.61M | 6.13M | 6.07M | 5.74M | 6.65M | 5.89M | 4.16M | 5.05M | 5.18M | 4.58M | 4.54M | 4.26M | 3.57M | 3.23M | 2.72M | 2.86M | 2.49M | 2.58M | 2.82M | 2.09M | 2.17M | 1.97M | 2.09M | 1.84M | 2.01M | 1.92M | 2.27M | 1.77M | 1.92M | 2.05M | 2.22M | 1.89M | 1.89M | 1.97M | 1.76M | 2.13M | 2.19M | 2.29M |
| Selling, General, and Administrative Revenue Growth | +4.92% | +1.47% | +7.76% | +1.05% | +5.68% | -13.70% | +12.92% | +41.58% | -17.67% | -2.38% | +13.11% | +0.88% | +6.45% | +19.25% | +10.58% | +18.65% | -4.85% | +15.00% | -3.40% | -8.52% | +34.60% | -3.60% | +10.01% | -5.34% | +13.15% | -8.54% | +5.20% | -15.67% | +28.61% | -7.82% | -6.58% | -7.58% | +17.63% | -0.10% | -4.37% | +12.05% | -17.39% | -2.50% | -4.42% | n/a |
| Research and Development Revenue | 3.33M | 3.31M | 3.12M | 2.63M | 2.65M | 2.43M | 3.6M | 3.02M | 3.62M | 2.45M | 2.28M | 2.53M | 2.73M | 2.63M | 2.12M | 1.56M | 1.82M | 1.21M | 822.3K | 829.53K | 880.33K | 761.88K | 697.8K | 584.54K | 481.29K | 617.24K | 665.31K | 546.33K | 582.16K | 589.72K | 1.08M | 557.7K | 529.71K | 691.33K | 749.94K | 657.19K | 522.61K | 480.28K | 426.93K | 527.51K |
| Research and Development Revenue Growth | +0.51% | +6.25% | +18.86% | -1.02% | +9.18% | -32.62% | +19.25% | -16.58% | +47.74% | +7.40% | -9.83% | -7.35% | +3.95% | +23.88% | +35.83% | -14.36% | +50.95% | +47.03% | -0.87% | -5.77% | +15.55% | +9.18% | +19.38% | +21.45% | -22.03% | -7.23% | +21.78% | -6.15% | -1.28% | -45.61% | +94.41% | +5.28% | -23.38% | -7.82% | +14.11% | +25.75% | +8.81% | +12.50% | -19.07% | n/a |
| Sales and Marketing Revenue | 3.81M | 3.55M | 3.83M | 3.29M | 3.35M | 2.84M | 3.47M | 2.93M | 3.19M | 2.14M | 2.19M | 1.84M | 1.84M | 1.83M | 1.59M | 1.57M | 1.47M | 1.49M | 1.12M | 1.3M | 1.51M | 1.06M | 1.14M | 1.04M | 879K | 764.6K | 926.23K | 962.21K | 1.01M | 899.1K | 979.9K | 1.07M | 3.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | +7.21% | -7.43% | +16.53% | -1.70% | +17.81% | -18.22% | +18.45% | -7.97% | +48.99% | -2.19% | +18.54% | +0.38% | +0.66% | +14.70% | +1.08% | +7.29% | -1.67% | +32.78% | -13.42% | -13.92% | +41.90% | -6.99% | +9.83% | +18.40% | +14.96% | -17.45% | -3.74% | -4.84% | +12.47% | -8.25% | -8.10% | -71.77% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |